https://freebeacon.com/politics/robby-mook-afghanistan/

Yet another former Hillary Clinton aide appears to have played a role in the Biden administration's botched Afghanistan withdrawal. Politico reported on Monday that Robby Mook, the Democratic operative who managed Hillary's failed presidential campaign in 2016, was at the Kabul airport performing public relations duties during the evacuation of U.S. citizens and Afghan allies from the Taliban-controlled country.

Mook, a lieutenant in the U.S. Navy Reserve, has been on active duty abroad since February after taking a hiatus from Democratic politics. In addition to managing Hillary's failed 2016 campaign, he was also a state director on her failed 2008 campaign. Most recently, Mook served as president of House Majority PAC during the 2020 election, when Democrats failed to defeat a single Republican incumbent and lost 13 seats in the House, despite winning the presidency.

According to Politico, the failed campaign operative was "part of a group of four public affairs officers dealing with press questions" at Hamid Karzai International Airport in Kabul. An anonymous source described him as "just doing his job" and said the former Hillary aide made a self-deprecating remark about not being recognized.

Murray 🇺🇸

@Rothbard1776

·

59m

Interesting news developing that two senior officials at the FDA are resigning due to frustrations regarding the vaccine approval process, in part as a result of undue influence from the CDC & their ACIP [Advisory Committee on Immunization Practices]. Worth watching.

@RWMaloneMD

https://endpts.com/breaking-in-a-major-blow-to-vaccine-efforts-senior-fda-leaders-stepping-down-report/

Two of the FDA’s most senior vaccine leaders are exiting from their positions, raising fresh questions about the Biden administration and the way that it’s sidelined the FDA.

Marion Gruber, director of the FDA’s Office of Vaccines Research & Review and 32-year veteran of the agency, will leave at the end of October, and OVRR deputy director Phil Krause, who’s been at FDA for more than a decade, will leave in November. The news, first reported by BioCentury, is a massive blow to confidence in the agency’s ability to regulate vaccines.

The bombshell announcement comes at a particularly crucial moment, as boosters and children’s shots are being weighed by the regulator. The departures also come as the administration has recently jumped ahead of the FDA’s reviews of booster shots, announcing that they might be available by the week of Sept. 20.

A former senior FDA leader told Endpoints that they’re departing because they’re frustrated that CDC and their ACIP committee are involved in decisions that they think should be up to the FDA. The former FDAer also said he’s heard they’re upset with CBER director Peter Marks for not insisting that those decisions should be kept inside FDA. What finally did it for them was the White House getting ahead of FDA on booster shots.

“These two are the leaders for Biologic (vaccine) review in the US. They have a great team, but these two are the true leaders of CBER. A huge global loss if they both leave,” Former BARDA director Rick Bright wrote, weighing in on the news. “Dr. Gruber is much more than the Director. She is a global leader. Visionary mastermind behind global clinical regulatory science for flu, Ebola, Mers, Zika, Sars-cov-2, many others.”

https://www.rt.com/usa/533570-mask-mandate-controversy-lawsuit/

Five states that banned mask mandates are under investigation and may be found in breach of disability law

The US Department of Education has warned school officials in five states that it is investigating whether their bans on mask mandates are “prevent[ing] students with disabilities from safely returning to in-person education.”

Officials in Iowa, Oklahoma, South Carolina, Tennessee, and Utah have been warned by the department’s Office of Civil Rights that, while the office hasn’t yet determined there had been a violation, the ban on universal indoor masking may prevent schools from meeting their legal obligations regarding providing an “equal educational opportunity” to disabled students at high risk for Covid-19.

The office has declined to look at Florida, Texas, Arizona, and Arkansas, noting that, while they have at various times adopted or considered blanket bans on mask mandates in schools, their plans for full-scale bans have been scuttled by “court orders or other state actions,” the DoE letter, sent on Monday, explained.